The Science

Dr Anne BangDrug screening research for L-CMD specific heart protection

Dr. Anne Bang’s work focuses on translational research and development utilizing hESC and hiPSC for cell therapy and drug discovery applications. In June 2010, Dr. Bang was recruited by the Sanford Burnham Institute, as Director of Cell Biology, to lead efforts to develop stem cell based disease modelling at the Prebys Center, a state of the art drug discovery facility. Dr. Bang’s experience in stem cell biology began in 2005 at ViaCyte, Inc., where, as Director of Stem Cell Research, she managed an interdisciplinary group working to develop hESC as a source of pancreatic cells for the treatment of diabetes. She received a BS from Stanford University, a Ph.D. from UCSD, and was a post-doc and Senior Scientist in the Neurobiology Laboratory at the Salk Institute.


Sanford-Burnham Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a U.S. based, non-profit public benefit corporation, with operations in San Diego (La Jolla) and Orlando (Lake Nona) in Florida.



  • Sanford-Burnham ranks #3 worldwide among all research organizations in citations per publication in the fields of biology and biochemistry for the most recent decade for which data is available.
  • Sanford-Burnham ranks #3 in the US among all laboratory-based life sciences research organizations in NIH grant funding.
  • In 2012, Sanford-Burnham researchers published 366 peer-reviewed scientific papers.
  • For every dollar of philanthropic support, the Institute has generated about $8 dollars of grant funding, thus effectively leveraging gifts 8:1. That’s the most efficient research operation among the Institute’s peer group of leading independent biomedical research institutes in the U.S.